Evidence map›Paper›PMID 41642934›Full record

ArticlePLoS pathogens2026

Antigen flexibility supports the avidity of hemagglutinin-specific antibodies at low antigen densities.

Ananya Benegal, Yuanyuan He, Katilyn Ho, Giselle Groff, Zijian Guo, Michael D Vahey

Abstract read
In one paragraph

Article in PLoS pathogens, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Full reach at arm's length.Biophysical journal · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Ananya BenegalDepartment of Mechanical Engineering and Materials Science, Washington University in St. Louis, St. Louis, Missouri, United States of America.
Yuanyuan HeCenter for Biomolecular Condensates, Washington University in St. Louis, St. Louis, Missouri, United States of America.
Katilyn HoCenter for Biomolecular Condensates, Washington University in St. Louis, St. Louis, Missouri, United States of America.
Giselle GroffCenter for Biomolecular Condensates, Washington University in St. Louis, St. Louis, Missouri, United States of America.
Zijian GuoCenter for Biomolecular Condensates, Washington University in St. Louis, St. Louis, Missouri, United States of America.
Michael D VaheyDepartment of Biomedical Engineering, Washington University in St. Louis, St. Louis, Missouri, United States of America.ORCID https://orcid.org/0000-0001-9453-4860

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The receptor-binding protein of influenza A virus, hemagglutinin (HA), is the most abundant protein on the viral surface. While high densities of HA are thought to improve cellular attachment by increasing avidity for the viral receptor, they may also increase the avidity of neutralizing antibodies. The tradeoff between these two competing effects of avidity is not well understood. To better understand how features of the viral surface influence antibody avidity, we developed fluorescence-based assays to measure dissociation kinetics and steady-state binding of antibodies to intact virions. Focusing on two antibodies that bind to the HA head domain (S139/1 and C05), we confirm that binding orientations that favor bivalent attachment of antibodies to the viral surface can offset weak monovalent affinity by facilitating crosslinking. By modulating HA density in both engineered viruses and synthetic nanoparticles, we find that bivalent antibody binding remains resilient down to one-tenth the HA density on the viral surface and, in the case of C05, that antibody occupancy increases at these lowest densities. Finally, using a combination of structure-guided modeling and antibodies that lock HA in a tilted conformation, we identify flexibility of the HA ectodomain as an additional determinant of antibody avidity. Together, these results establish features of the viral surface that help support or suppress the binding of neutralizing antibodies.

Indexed as

Antibodies, NeutralizingAntibodies, ViralAntibody AffinityAntigens, ViralHemagglutinin Glycoproteins, Influenza VirusInfluenza A virusAnimalsHumansAntibodies, NeutralizingAntibodies, ViralAntigens, ViralHemagglutinin Glycoproteins, Influenza Virus

Identifiers

PMID41642934
PMCPMC13020973

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.